Publisher： Bentham Science Publishers
E-ISSN： 1873-5576|16|9|755-764
ISSN： 1568-0096
Source： Current Cancer Drug Targets, Vol.16, Iss.9, 2016-10, pp. : 755-764
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. :
Access to resources
Recommend
Indoleamine 2,3-dioxygenase, Tregs and Cancer
Current Medicinal Chemistry, Vol. 18, Iss. 15, 2011-05 ,pp. :
Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer
Current Cancer Drug Targets, Vol. 7, Iss. 1, 2007-02 ,pp. :
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 2, 2009-06 ,pp. :